low oxygen therapy: Clinical Trials

2 trials of low oxygen therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Not yet recruiting 1
Phase 22Active not recruiting 1, Not yet recruiting 1

Follow low oxygen therapy: new trials by email Literature Review of low oxygen therapy trials Research Report on low oxygen therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury
Istradefylline, low oxygen therapy - Spinal Cord Injuries, Myelopathy
Phase 1 / Phase 2Not yet recruitingRandy Trumbower, PT, PhD402027-09-012026-03-20
Adenosine 2A Receptor Antagonism and AIH in ALS
Consume 20mg of istradefylline, Low Oxygen therapy, Placebo counterpart to the istradefylline drug - ALS
Phase 1 / Phase 2Active not recruitingUniversity of Florida402022-06-212026-03-27

Conditions studied

Hypoxia (1)  ·  Respiratory Aspiration (1)  ·  Spinal Cord Diseases (1)  ·  Spinal Cord Injuries (1)

Sponsors

Randy Trumbower, PT, PhD (1)  ·  University of Florida (1)

Countries

United States (2)

Top investigators

Barbara Smith (1)  ·  Randy D Trumbower, PT, PhD (1)

Results publications

PMID 41202295